ARCHIVES

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

NIH closes Meeting of BSC Chairmen, Violation of Open Meetings Law Alleged

August 5, 1994

More Changes In Carcinogenesis Program At NCI: Gori, Workshops Out, Branch Chiefs Running It

November 18, 1977

Act To Get Only One-Year Extension Now NCAB; ACCC, ACI Adopt Recommendations For changes

February 4, 1977

Hammer Says He’ll Demand Construction Funds If Data Supports The Need

August 12, 1983

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

February 17, 1989

Institutions Fail To Credit NIH when Patenting discoveries, HHS Says

July 15, 1994